Temporal arteritis

Journal of the Chinese Medical Association

Volumn 68, Issue 7, 2005, Pages 333-335

  Chen, Chun Hsiung ^a,b   Kung, Shih Ya ^a   Tsai, Ying Yang ^a   Liao, Hsien Tzung ^a,b   Chou, Chung Tei ^a,b   Huang, De Feng ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anticardiolipin antibody; Multinucleated giant cell; Temporal arteritis

Indexed keywords

AZATHIOPRINE; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PREDNISOLONE;

AGED; ARTICLE; BLOOD VESSEL BIOPSY; CASE REPORT; CLINICAL PROTOCOL; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HEADACHE; HOSPITAL ADMISSION; HUMAN; INTERMITTENT CLAUDICATION; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; TEMPORAL ARTERITIS;

EID: 21844461328     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70170-4     Document Type: Article

References (9)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
2. Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, O'Fallon WM. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
3. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 1990;33:1074-87.
4. Duhaut P, Berruyer M, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Dechavanne M, et al. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Arthritis Rheum 1998;41:701-9.
5. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
6. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996;101:576-83.
7. Liozon E, Roblot P, Paire D, Loustaud V, Liozon F, Vidal E, Jauberteau MO. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology 2000;39:1089-94.
8. Manna R, Latteri M, Cristiano G, Todaro L, Scuderi F, Gasbarrini G. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol 1998;37:208-10.
9. Chakravarty Y, Pountain G, Merry P, Byron M, Hazleman B, Scott DG. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1995;22:1694-7.